Sarepta pulls plug on Duchenne exon-skipping drug

Sarepta pulls plug on Duchenne exon-skipping drug

Submitted by admin on November 7, 2024 - 11:09am
Source: 
Pharmaphorum
News Tags: 
Sarepta Therapeutics
Duchenne Muscular Dystrophy
DMD
vesleteplirsen
Headline: 
Sarepta pulls plug on Duchenne exon-skipping drug
snippet: 

Sarepta Therapeutics has decided not to continue the development of vesleteplirsen, a follow-up to its Duchenne muscular dystrophy (DMD) therapy Exondys 51.

Do Not Allow Advertisers to Use My Personal information